The FDA approves the Pfizer COVID-19 vaccine in adolescents
It is now approved for teenagers between the ages of 12 and 15.
Pfizer was the first vaccine to be approved in December 2020 to fight the COVID-19 pandemic.
Acting FDA Commissioner Janet Woodcock, MD made the following statement on enlargement.
“The FDA’s extension of emergency approval for the Pfizer-BioNTech COVID-19 vaccine to adolescents ages 12-15 is an important step in the fight against the COVID-19 pandemic,” said Acting FDA Commissioner Janet Woodcock , MD “Today’s action is making it possible to protect a younger population from COVID-19, which brings us closer to returning to a sense of normalcy and ending the pandemic. Parents and guardians can rest assured that the agency has carried out a rigorous and thorough review of all available data, as we have done with all of our COVID-19 emergency vaccine approvals. “
This is an evolving story that is being updated.